CRIS Current Research Information System

MUSIANI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.946
EU - Europa 4.420
AS - Asia 2.125
AF - Africa 273
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
OC - Oceania 1
Totale 11.771
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.929
GB - Regno Unito 1.337
VN - Vietnam 724
CN - Cina 708
DE - Germania 593
UA - Ucraina 563
SE - Svezia 549
IT - Italia 504
SG - Singapore 323
IN - India 260
FR - Francia 193
RU - Federazione Russa 189
IE - Irlanda 172
EE - Estonia 93
ZA - Sudafrica 88
CH - Svizzera 81
TG - Togo 78
SC - Seychelles 53
BG - Bulgaria 41
JP - Giappone 37
BE - Belgio 31
IR - Iran 30
NG - Nigeria 30
CI - Costa d'Avorio 24
GR - Grecia 17
FI - Finlandia 16
JO - Giordania 16
CA - Canada 14
RO - Romania 12
AT - Austria 10
NL - Olanda 9
UZ - Uzbekistan 8
LB - Libano 7
EU - Europa 4
IQ - Iraq 3
HK - Hong Kong 2
IL - Israele 2
PL - Polonia 2
PR - Porto Rico 2
AR - Argentina 1
CL - Cile 1
CZ - Repubblica Ceca 1
ES - Italia 1
HU - Ungheria 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
MD - Moldavia 1
MT - Malta 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
Totale 11.771
Salva come PNG Salva come JPEG
Città #
Southend 1.162
Chandler 541
Dong Ket 501
Ashburn 482
Fairfield 455
Jacksonville 430
Singapore 270
Wilmington 260
Princeton 246
Ann Arbor 237
Woodbridge 236
Seattle 227
Houston 214
Dublin 172
Cambridge 160
Westminster 119
Padova 118
Nanjing 106
Berlin 94
Medford 79
Lomé 78
Bern 74
Mülheim 69
Saint Petersburg 66
New York 54
Milan 53
Mahé 52
Jinan 48
Shenyang 48
Santa Clara 46
Sofia 41
Redwood City 40
Nanchang 37
Tokyo 37
Changsha 34
Beijing 33
Boardman 32
Brussels 31
Abeokuta 30
Tianjin 30
Bologna 29
Hebei 28
Florence 26
Verona 26
Abidjan 24
Bremen 24
Jiaxing 23
Hangzhou 22
Des Moines 21
Zhengzhou 21
Olalla 20
San Diego 20
Guangzhou 18
Dearborn 17
Paris 17
Taizhou 17
Amman 16
Helsinki 16
Norwalk 16
Ningbo 14
Kunming 13
San Venanzo 13
Shanghai 13
Haikou 12
Rome 12
Taiyuan 12
Falls Church 11
Hyderabad 11
Kuban 11
Los Angeles 11
Pune 11
Ardabil 10
Tappahannock 10
Toronto 10
Lanzhou 9
Bühl 8
Leawood 8
Monmouth Junction 8
Mountain View 8
Wuhan 8
Fuzhou 7
Phoenix 7
Shenzhen 7
Vienna 7
Zanjan 7
Andover 6
Changchun 6
Hefei 6
Quanzhou 6
Rimini 6
Augusta 5
Catania 5
Chengdu 5
Chongqing 5
Frankfurt Am Main 5
Stockholm 5
Turin 5
Washington 5
Buffalo 4
Edinburgh 4
Totale 7.779
Salva come PNG Salva come JPEG
Nome #
A new primer set improves the efficiency of competitive PCR-ELISA for the detection of B19 DNA 184
Bio- and chemiluminescence imaging in analytical chemistry 154
Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis 153
Presence of high-risk mucosal human papillomavirus genotypes in primary melanoma and in acquired dysplastic melanocytic naevi 152
Analisi dell’integrazione del DNA di HPV16 in campioni cervicali, mediante PCR qualitativa e quantitativa 151
A miniaturized multiplexed analytical device with chemiluminescence "contact" imaging detection for diagnostic applications 151
Assessment of the presence of mucosal human papillomaviruses in malignant melanomas using combined fluorescent in situ hybridization and chemiluminescent immunohistochemistry 151
Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus 147
Bio-chemiluminescent miniaturized biosensors 144
A proteomic approach to the analysis of B19 capsid proteins 142
Presence and type of oncogenic human papillomavirus in classic and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma 138
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 137
Analysis of Parvovirus B19 DNA methylation status in experimental and natural infections. 137
Analysis by real-time PCR of B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines 136
Analysis of HPV16 E6*I-II transcripts in cervical samples 135
Infezione da Parvovirus B19 nella donna in gravidanza, nel feto e nel neonato. 134
Efficient treatment of paraffin-embedded cervical tissue for HPV DNA testing by HC-II and PCR assays 131
Combined fluorescent DNA in situ hybridization and chemiluminescent immunohistochemistry for the co-localization of mucosal human papillomavirus and malignant melanoma 131
Sviluppo di un saggio di Real- Time PCR per la quantificazione del DNA di HPV in campioni citologici cervicali 131
High-throughput polymerase chain reaction chemiluminescent enzyme immunoassay for typing and quantifying human papillomavirus DNAs 130
Ricerca e determinazione del carico virale di parvovirus B19 mediante tecnica di Real-time PCR calibrata 128
Analisi della competenza funzionale di cloni genomici di parvovirus B19 127
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicale in situ 126
Comparative evaluation of an automated assay for parvovirus B19 antibody detection 126
Analysis of E6* spliced products of HPV16 as molecular markers of cervical disease progression. 124
Recurrent erythema in patients with long-term parvovirus B19 infection 122
Analysis of splice junctions and polyadenylation sites of parvovirus B19 genome by a PCR-based approach 121
Ricerca del parvovirus B19 nello screening per la sicurezza degli emoderivati 120
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 120
Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias 120
Analisi del DNA di HPV 16 e degli mRNA E6/E7 in campioni citologici cervicali 120
Application of the NASBA method for the detection of human papillomavirus E6-E7 transcripts in patients treated for high grade CIN and positive to HPV16 119
Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions 117
Correlazione tra presenza del DNA di HPV ed espressione della P16INK4A in lesioni benigne e maligne della vulva 116
Analisi funzionale del genoma di parvovirus B19 in due sistemi sperimentali: infezione in vitro e trasfezione con cloni ricombinanti 116
Calibrated real-time PCR for evaluation of parvovirus b19 viral load 116
Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens. 116
Competitive PCR-ELISA protocols for the quantitative and the standardized detection of viral genomes. 115
Peptide nucleic acid-based in situ hybridization assay for detection of parvovirus B19 nucleic acids 112
Chemiluminescent assay for p16INK4A quantitation in cervical biopsies combined with fluorescent HPV DNA in situ hybridisation 112
Presenza e ruolo della metilazione dei dinucleotidi CpG nel DNA di parvovirus B19. 111
High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups. 111
Analisi della competenza funzionale di cloni genomici di parvovirus B19 per lo sviluppo di vettori virali 110
B19 in vitro infection of permissive systems: a quantitative analysis of virus replication and expression 110
Functional analysis and quantitative determination of the expression profile of human parvovirus B19 109
Determination of physical status and viral load of HPV 16 DNA in cytological cervical samples by quantitative PCR assays 108
HPV DNA patterns and disease implications in the follow-up of patients treated for HPV16 high-grade carcinoma in situ 108
Evidence of human bocavirus viremia in healthy blood donors. 107
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicali in situ 106
Rivelazione e caratterizzazione di varianti genotipiche di parvovirus B19 in sangue proveniente da unità trasfusionale 104
Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors 104
Presence and type of oncogenic human papillomavirus in classic VIN, differentiated VIN and keratinizing VSCC 103
Qualitative PCR-ELISA protocol for the detection and typing of viral genomes. 103
Molecular luminescence imaging 103
Quantitative immunohistochemistry and in situ hybridization with luminescence detection: a new potential diagnostic tool 103
Analysis of the functional competence of genomic clones of Parvovirus B19 103
Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment 102
Espressione e purificazione di gamma-interferon bovino bioattivo in baculovirus 101
Evaluation of quantitative PCR assays for the determination of physical status and viral load of HPV16 DNA 101
Parvovirus B19 genome as a single, two-state replicative and transcriptional unit 101
Quantitative immunohistochemistry and in situ hybridization with luminescence detection: a new potential diagnostic tool 98
Quantitative immunohistochemistry and in situ hybridization imaging procedures with luminescence detection: a new potential diagnostic tool 97
Follow up of patients treated of HPV 16 high-grade CIN: HPV DNA patterns and disease implication 96
Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion. 96
Catalytic partial oxidation of CH4-H2mixtures over Ni foams modified with Rh and Pt 96
Parvovirus B19 infection during pregnancy and evaluation of fetal outcomes 95
Parvovirus B19-derived fetal complications following gestational infection. 95
Sviluppo di un metodo di ibridazione in situ fluorescente e immunoistochimica chemiluminescente combinate per la colocalizzazione di DNA di papillomavirus umano e di un marker melanocitico tumorale 93
Parvovirus B19 DNA Is Commonly Harboured in Human Skin. 93
Human papillomavirus in melanoma: reply from authors 93
Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman 92
Metodo di real time PCR in due step per la definizione di gruppi di rischio di HPV e per la quantificazione genotipo specifica 92
Correlazione tra presenza di HPV, carica e integrazione virale in lesioni (pre)neoplastiche vulvari 89
Valutazione del rischio di insorgenza di nefropatia associata a polyomavirus nello screening di trapiantati renali 88
Valutazione della correlazione tra presenza di HPV ed espressione della P16 INK4A in lesioni vulvari e cervicali mediante FISH combinata ad IHC con rivelazione chemiluminescente 87
HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection. 87
Detection of parvovirus B19 IgG: choice of antigens and serological tests 87
Diagnosi virologica di infezione da papillomavirus umani 86
Implicazioni nella progressione della patologia cervicale 86
Comparison of abbott realtime HPV assay and digene HC2 HPV DNA test for the detection of high-risk HPV DNA in a referral population setting Source: JOURNAL OF CLINICAL VIROLOGY Volume: 46 Pages: S49-S49 Supplement: Suppl. 1 Published: SEP 2009 86
Quantitative evaluation of HBoV DNA in serum samples from Italian population. 85
Studio dell’espressione di parvovirus B19 in sistemi permissivi e non mediante real-time PCR 85
Detection of HPV 16 E6-E7 transcripts in cervical cytological samples and correlation with HPV-DNA physical status 83
Persistent parvovirus B19 infection resulting in carpal tunnel syndrome 83
Valutazione della persistenza di diversi genotipi di HPV nel follow-up di pazienti trattate per lesioni cervicali di alto gradi 82
Development of a miniaturized analytical device employing luminescence “contact” imaging detection for parvovirus B19 infection diagnosis 82
Colorimetric and chemiluminescent Peptide Nucleic Acid-based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 82
Functional analysis of B19 virus genome by transcript-specific quantitative real-time PCR 80
Multiplex chemiluminescence microscope imaging of P16INK4A and HPV DNA as biomarker of cervical neoplasia 80
Sviluppo di un metodo di ibridazione in situ fluorescente e immunoistochimica chemiluminescente combinate per la co-localizzazione di DNA di papillomavirus umano e di un marker melanocitico tumorale 77
PNA-Based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 77
Clonazione, espressione e purificazione di g-IFN bovino ricombinante in baculovirus 75
Sviluppo di un metodo di ibridazione in situ fluorescente e immunoistochimica chemiluminescente combinate per la co-localizzazione di DNA di papillomavirus umano e di un marker melanocitico tumorale 74
Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination 74
Quantitative immunohistochemistry and in situ hybridisation imaging procedures with luminescence detection: a new potential diagnostic tool 74
Nuovo saggio FISH per la ricerca del DNA di HPV combinato ad IHC chemiluminescente per la quantificazione di p16 INK4A in lesioni cervicali 74
PNA-based probe for quantitative chemiluminescent in situ hybridisation imaging of cellular parvovirus B19 replication kinetics 72
Ricerca di HPV ad alto rischio oncogeno: Abbott Real Time HPV Assay e Digene HC2 HPV DNA Test a confronto 70
B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines – a quantitative analysis by real-time PCR 69
Quantitative immunohistochemistry and in situ hybridization imaging procedures with luminescence detection: a new potential diagnostic tool 68
Totale 10.748
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.821
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.943 0 0 0 185 205 244 260 358 270 189 90 142
2020/20212.071 385 108 48 99 26 125 37 106 121 107 108 801
2021/20222.130 164 110 140 224 179 116 22 116 67 226 354 412
2022/20232.297 247 339 126 272 177 139 57 137 358 45 236 164
2023/2024798 42 94 39 128 44 165 108 63 18 33 21 43
2024/2025727 80 359 221 67 0 0 0 0 0 0 0 0
Totale 12.024